Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-10-03
1991-10-29
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514310, A61K 3147
Patent
active
050617150
ABSTRACT:
This invention relates to quinolyloxazole-2-ones which are useful anti-enveloped virus agents by virtue of their ability to act as protein kinase C inhibitors. These derivatives are disclosed to be effective in treating enveloped virus infections including HIV infections and are thus useful in the treatment of AIDS and ARC.
Jones Winton D.
Sunkara Sai P.
Goldberg Jerome D.
Merrell Dow Pharmaceuticals Inc.
Nesbitt Stephen L.
LandOfFree
Prevention of glycoprotein enveloped virus infectivity by quinol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention of glycoprotein enveloped virus infectivity by quinol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of glycoprotein enveloped virus infectivity by quinol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1400835